Biotech
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 05/16/16 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced that its commercial partner, Sanofi, along with Theratechnologies, have decided to wit ...
DUBLIN, IRELAND: Presentation at American Thoracic Society 2016 International Conference Suggests Potential Efficacy and Overall Mortality Benefits for Select HABP/VABP Patients With VIBATIV Therapy; Shows No Statisti ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 05/16/16 -- (NASDAQ: CBLI) today reported financial results and development progress for the first quarter ended March 31, 2016.Cleveland BioLabs reported a net loss, ...
TORONTO, ONTARIO: TTI-621 Phase I clinical trial progressing according to plans Completed acquisition and integration of Fluorinov Cash amounted to $65.8 million as of March 31, 2016 ...
SYDNEY, AUSTRALIA and SEATTLE, WA: SYDNEY, AUSTRALIA and SEATTLE, WA -- (Marketwired) -- 05/12/16 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD)Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima") and U.S.-based Sydys Corpora ...
Lincoln: SMi Group reports (2016.05.11, San Diego, California, USA): FDA will provide the latest updates on Pre-Filled Syringes and Combination Products at Pre-Filled Syringes West Coast 2016.
SMi are delig ...
MONTREAL, QC: MONTREAL, QC -- (Marketwired) -- 05/11/16 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of v ...
DUBLIN, IRELAND: Presentation to Highlight HABP/VABP Patient Populations, Including Those With MRSA, for Which VIBATIV May Serve as an Appropriate Treatment ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 05/10/16 -- (NYSE MKT: MDGN)(NYSE MKT: MDGN) (the Company) today announced first quarter 2016 financial results, as well as interim data from its groundbreaking ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 05/10/16 -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV)(OTCQB: RVVTF), a company focused on commercializing treat ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 05/09/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported financial results for the first ...
ATLANTA, GA: ATLANTA, GA -- (Marketwired) -- 05/09/16 -- True Nature Holding, Inc. (OTCQB: TNTY) ("the Company") announced today that, subject to approval by the Georgia Board of Pharmacy, it has comple ...
DUBLIN, IRELAND: Updated Label Includes Data Describing VIBATIV Use Against Concurrent Bacteremia in Approved Indications ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 05/09/16 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializ ...
LEXINGTON, MA: Company to Provide Corporate Update and First Quarter Financial Results Announcement of the Second Positive Phase II Clinical Trial of NS2 in 2016 NS2 Has Now Demonstrated Clinical Activity in the Two ...
ORLANDO, FL: ORLANDO, FL -- (Marketwired) -- 05/06/16 -- CEOLIVE, Inc., A provider of in-depth video interviews with public company CEO's (), announced today that a new interview with Gregg Gellman, Director ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 05/06/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 05/05/16 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehyde ...
SEATTLE, WA: Conference Call to Be Held Today at 4:30 pm Eastern Time ...
